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Leptin differentially regulate STAT3 activation in
ob/ob mouse adipose mesenchymal stem cells
Zhou Zhou1†, Manish Neupane2,6†, Hui Ren Zhou1†, Dayong Wu3, Chia-Cheng Chang4,
Naima Moustaid-Moussa5 and Kate J Claycombe1,7*
Abstract
Background: Leptin-deficient ob/ob mice exhibit adipocyte hypertrophy and hyperplasia as well as elevated
adipose tissue and systemic inflammation. Multipotent stem cells isolated from adult adipose tissue can
differentiate into adipocytes ex vivo and thereby contribute toward increased adipocyte cell numbers, obesity,
and inflamm ation. Currently, information is lacking regarding regulation of adipose stem cell numbers as well as
leptin-induced inflammation and its signaling pathway in ob/ob mice.
Methods: Using leptin deficient ob/ob mice, we investigated whether leptin injection into ob/ob mice increases
adipose stem cell numbers and adipose tissue inflammatory marker MCP-1 mRNA and secretion levels. We also
determined leptin mediated signaling pathways in the adipose stem cells.
Results: We report here that adipose stem cell number is significantly increased following leptin injection in ob/ob
mice and with treatment of isolated stem cells with leptin in vitro. Leptin also up-regulated MCP-1 secretion in a
dose- and time-dependent manner. We further showed that increased MCP-1 mRNA levels were due to increased
phosphorylation of Signal Transducer and Activator of Transcription 3 (STAT3) Ser727 but not STAT3 Tyr705
phosphorylation, suggesting differential regulation of MCP-1 gene expression under basal and leptin-stimulated
conditions in adipose stem cells.
Conclusions: Taken together, these studies demonstrate that leptin increases adipose stem cell number and
differentially activates STAT3 protein resulting in up-regulation of MCP-1 gene expression. Further studies of
mechanisms mediating adipose stem cell hyperplasia and leptin signaling in obesity are warranted and may help
identify novel anti-obesity target strategies.
Keywords: Obesity, Adipose stem cell, Leptin
Background
Obesity increases the risk for developing Type 2 Dia-
betes (T2D), cardiovascular disease (CVD), and cancer
[1]. The elevated risk has been suggested to be mediated,
in part, by increased chronic inflammation [2]. Elevated
secretion of pro-inflammatory cytokines with obesity is
significantly reduced with weight loss, particularly with
decreased body fat [3,4]. These findings suggest that adi-
pose tissue is an important source of obesity-associated
inflammation. We previously showed that adipose tissue
stem cells (CD34+) isolated from leptin-deficient obese
ob/ob mice secrete high levels of Monocyte Chemotactic
Protein-1 (MCP-1) [5]. This adipokine may have a
more profound effect on adipose tissue inflammation,
compared to other inflammatory factors secreted from
adipose tissue, such as tumor necrosis factor-alpha
(TNF-alpha), interleukin(IL)-1, IL-6, IL-8, and IL-18
[6]. This may be due to MCP-1’s chemotatic activity
which causes infiltration and accumulation of macrophages
(Mφ) in adipose tissue [7-9], thus further exacerbating
adipose tissue inflammation [7-9].
Leptin is considered to be a member of the pro-
inflammatory IL-6 family of cytokines [10]. Leptin mod-
ulates humoral and cell-mediated immune responses
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[11-15]. In agreement with this immune regulatory role,
the long form of leptin receptor (Ob-RL) is expressed in
immune cells such as monocytes and T cells [16], den-
dritic cells [17], eosinophils [18], B cells [19], and Mφ
[20]. Leptin receptors are localized on adipose tissue
cells [21]. Leptin binding to the leptin receptor stimu-
lates stem cell proliferation [20], differentiation [22,23]
and cytokine secretion from adipose tissue [24], possibly
via Janus Kinase (JAK)-Signal Transducer and Activator
of Transcription 3 (STAT3) signaling pathways [25].
Typically, leptin induces proinflammatory cytokine ex-
pression also via activation of leptin receptor followed
by activation of JAK 2/3 and STAT3 pathways [12,26]. In
addition to JAK2/3-STAT3 pathway, other non-traditional
cytokine type receptor signaling molecules such as insulin
receptor substrate-1 (IRS-1), phosphoinositide 3-kinase
(PI3K), protein kinase B/Akt (PKB/Akt) also mediate the
proinflammatory effects of leptin [27,28]. Interestingly,
studies have shown that MCP-1 gene expression is regu-
lated in STAT3 dependent manner [29]. Previously, we
have shown that differences in serum MCP-1 between
lean and leptin deficient obese (ob/ob) mice might be due
to an increased MCP-1 expression in adipose tissue; in
addition, among the adipose tissue subtype cells that are
capable of secreting MCP-1, CD34+ cells are the primary
contributors toward elevated serum MCP-1 levels in the
ob/ob mice [5]. It is plausible that CD34+ cells play key
role in obesity-associated inflammation since obesity is
associated with elevated levels of inflammation and that
CD34+ cells contribute to the elevated inflammation by
secreting MCP-1. Recently, a subpopulation of mouse
CD34+ cells has been identified as precursors of white
adipocytes, bone, cartilage, and muscle in vitro [30].
Additional studies have demonstrated that cell surface
markers such as CD34 and stem cell antigen 1 (Sca-1)
are found in adipose-derived mesenchymal stem cells
(Ad-MSCs) [30]. Therefore, we hypothesized that MCP-
1 secreting CD34+ cells from ob/ob mice adipose tissue
have mesenchymal stem cell (MSC) phenotypes. In
addition, several obesity-associated factors and conditions
such as hyperglycemia, hyperinsulinemia, and inflamma-
tion, all of which are present in ob/ob mice [31-34], can
induce MCP-1 secretion from adipocytes [35-37]. There-
fore, it is plausible that a common adipose-derived and
circulating factor such as leptin, accounts for increased
MCP-1 as well as the above metabolic alterations in obes-
ity. Leptin-mediated MCP-1 secretion has been shown in
immune cells such as eosinophils [38]. However, no stud-
ies addressed whether leptin injection into leptin deficient
ob/ob mice increases plasma MCP-1 concentration.
The current study tested whether adipose tissue mass,
numbers of adipose tissue SVF cells and MSC numbers
are altered with obesity in the ob/ob model. The current
study also tested whether leptin injection to ob/ob mice
increased plasma and adipose MCP-1expression and fur-
ther dissected the intracellular signaling pathways
involved in adipose MCP-1expression.
Methods
Mice
Four-month-old male wild-type C57BL/6J and leptin-
deficient obese C57BL/6J-ob/ob (ob/ob) mice were pur-
chased from The Jackson Laboratory (Bar Harbor, ME).
Epididymal white adipose tissue samples were used to
isolate adipose tissue cells. The study protocol was
reviewed and approved by the Michigan State University
Institutional Animal Care and Use Committee.
Cell culture Reagents. Recombinant murine leptin
was purchased from PeproTech (Rocky Hill, NJ) with an
endotoxin level less than 0.1 ng per μg (1EU/μg). Inhibi-
tors: JAK inhibitor I, AG 490, Akt inhibitor IV and U-
0126 were purchased from Calbiochem (La Jolla, CA).
LY294002 was purchased from Cell Signaling Tech-
nology, Inc. (Danvers, MA). Rabbit polyclonal anti-
bodies against phospho-STAT3 (Tyr705), phospho-STAT3
(Ser727), STAT3, phospho-p44/42 MAP kinase (Thr202/
Tyr204), p44/42 MAP kinase, phospho-Akt (Ser473),
phospho-Akt (Thr308), Akt (pan) rabbit mAb, phospho-
PI3K p85(Tyr458) and PI3 Kinase p85 rabbit mAb were
purchased from Cell Signaling Technology.
Isolation of stromal vascular fraction (SVF) and
magnetic cell sorting (MACS) analysis. Epididymal
white adipose tissue was excised from lean control and ob/
ob mice. Samples were minced and digested using 0.25%
collagenase (2 mg/ml of collagenase type I, Worthington
Biochemical, Lakewood, NJ) in Hanks' balanced salt solu-
tion (HBSS) at 37°C and digested adipose tissue cells were
filtered through 100-μm nylon cell strainers (BD Bios-
ciences, Bedford, MA). The floating adipocytes were
removed after centrifugation (450 X g), and the pellet was
washed and resuspended in DMEM supplemented with
10% heat-inactivated fetal bovine serum (HIFBS; GIBCO,
Grand Island, New York), 100 IU penicillin (P), and 100
μg/ml streptomycin (S). The resulting SVF cell pellet was
treated with red blood cell lysis buffer, washed with PBS
and resuspended in DMEM for hemocytometer counting
and isolation of CD34+ cells. SVF cells were first stained
with 10 μg each of R-phycoerythrin (PE)-conjugated anti-
CD34 (ebioscience, San Diego, CA), Sca-1 (eBioscience),
CD45 (eBioscience), and F4/80 antibodies (Invitrogen,
Carlsbad, CA) by mixing and incubating these antibodies
separately with 1×107 cells in 100 μl of MACS buffer (Mil-
tenyi Biotec, Auburn, CA) with 10 μl of blocking buffer
(Miltenyi Biotec). The cells were then incubated for 10 min
in the dark at 4°C, washed, and magnetically labeled with
20 μl anti-PE microbeads (Miltney Biotec), by resuspending
cells with PE microbeads in 80 μl of MACS buffer for 15
min at 4°C. The cells were washed and resuspended in 1
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ml of MACS buffer, and loaded on a magnetic column that
was placed in MACS separator in order to retain the mag-
netically labeled cells and to elute unlabeled cells. After re-
moval of the column from the magnetic separator, the
CD34+ cells were eluted with MACS buffer and resus-
pended in DMEM medium with 10% HIFBS and P/S. Cells
were then plated in 60 mm cell culture dishes, grown to
confluence, and subcultured or cryopreserved for further
studies.
Fluorescence activated cell sorting (FACS) analysis.
Mouse CD34, Sca-1, and CD45 FITC or PE conjugated
antibodies and their IgG isotype control antibodies were
purchased from BD Biosciences. MACS-separated CD34+
cells were resuspended in 500 μl of fixation buffer
(eBioscience) followed by room temperature incubation for
15 min. The resulting cells were washed with the staining
buffer (eBioscience) twice, centrifuged at 500 rpm for 5
min at 4°C and resuspended in 300 μl staining buffer con-
taining appropriate antibody at 1 μg/1x106 cells. Antibody
solution containing cells was then incubated in the dark for
1 hr at room temperature, washed in staining buffer twice
and then resuspended in 500 μl of staining buffer for FACS
analysis. The stained samples were analyzed by FACS Vant-
age equipped with a G3 Mac computer and CellQuest soft-
ware (Becton-Dickinson, San Jose, CA). Single- and two-
color controls were used to set the lower limit of positive
fluorescence and compensation for spectral overlap of these
fluorochromes. Data based on 20,000–50,000 events were
acquired from each sample and analyzed using WinLis 5.0
(Verity Software House, Topsham, ME).
Differentiation of Sca-1+/CD45-/CD34+ cells. MACS-
separated early passage (passage 3) cells as well as cells
expanded in different culture conditions for various time
periods were used for differentiation studies. The cells
were treated with different induction cocktails in D
medium (a modified Eagle’s Minimum Essential
Medium) with 10% FBS. All studies were carried out
with same number of controls. For osteogenesis, cells
were plated at the seeding density of 3,000 cells/cm2 in 6-
well plates (regular or laminin-coated) and treated with
dexamethasone (0.1 μM), L-ascorbic acid 2-phosphate
(Asc 2P, 50 μM) and β-glycerophosphate disodium
(10 mM) (DAG cocktail) in D medium containing 10%
FBS for 4 weeks, with medium change once in every 3
days. We optimized the differentiation protocol by omit-
ting dexamethasone from the induction regimen, and
treating the cells with 5-fold higher concentration of Asc
2P (250 μM), and β-glycerophosphate disodium (10 mM)
(AG cocktail) in D medium containing 10% FBS for 4
weeks, with medium changed once every 3 days. Alizarin
red staining was performed to detect calcified extracellu-
lar matrix deposits. For chondrogenesis, the micromass
culture method was used. 1 × 105 cells in 10 μL volume
were plated in each of 3 wells in a 24-well plate and
incubated for 2.5 hours and then treated by transforming
growth factor-beta 1 (TGF-β1,10 ng/ml), Asc 2P (50 μM)
and insulin (6.25 μg/ml) (TAI cocktail) for 14 days, with
medium change once every 3 days. The micromasses
were stained with Alcian blue to detect the presence of
sulfated proteoglycan-rich matrix. For adipogenesis, cells
were plated at the seeding density of 10,000 cells/cm2 in
6-well plates, and treated with the standard protocol of 3-
isobutyl-1-methylxanthine (IBMX, 500 μM), dexametha-
sone (1 μM), indomethacin (100 μM), and insulin (10 μg/
ml) (IDII cocktail) for 21 days, with medium change once
in every 3 days. We optimized the adipogenic induction
cocktail for these CD34+ mAd-MSCs as follows. Cells
were plated at the seeding density of 5000 cells/cm2 in 60
mm plates, and treated with prostaglandin J2 (15 μM)
(Cayman Chemical), dexamethasone (1.5 μM), insulin
(600 nM), and glucose (6.75 mg/ml) (PDIG cocktail) for 14
days, with medium change once in every 3 days. Oil Red O
staining was done to examine the lipid droplet formation.
Enzyme-Linked Immunosorbant Assay (ELISA).
MCP-1 ELISA was performed according to the manufac-
turer’s procedure using a mouse CCL2/JE Duoset ELISA
Development Kit (R & D systems, Minneapolis, MN).
Briefly, MCP-1 antibodies were immobilized in microti-
ter plates. MCP-1 standard solutions and the super-
natant from different treatment were applied to the
pre-coated wells and incubated for 2h at RT. Unbound
proteins were washed away and MCP-1-antibody was
added to each well and incubated for 2h at RT. Next,
HRP-conjugated MCP-1-antibody was added to each
well and incubated for 20min at RT after washing. HRP
substrate was added and further incubated at RT for 20
min following washing steps. The reaction was stopped
and absorbance was measured in the microtiter plate
reader (Molecular Devices Corporation, Menlo Park,
CA) at 450 nm and 570 nm for λ-correction.
Real Time PCR. Total RNA was extracted from
Sca-1+/CD45-/CD34+ cells using a RNeasy Mini Kit
(Qiagen, Valencia, CA). 100 ng/μl of total RNA were
used to measure MCP-1 mRNA by real time PCR. The
primers, probe and endogenous control (18S-rRNA) were
purchased as Taqman assay reagents (Applied Biosystems,
Foster City, CA). Taqman One Step PCR Master Mix (Ap-
plied Biosystems) was used to quantify MCP-1 and 18S-
rRNA following manufacturer’s instructions on an ABI
Prism 7900 (Applied Biosystems). 18S-rRNA was used to
normalize target gene expression. Target gene expression
levels were calculated relative to the control group. For
PCR assays, total RNAs were extracted from cells using
Versagene RNA Purification Kit (Gentra) and treated with
DNase I (Turbo DNA-free) (Ambion) to remove contamin-
ating DNA. cDNAs were synthesized from 1 μg total RNA
using anchored oligo dT primers and Superscript III re-
verse transcriptase (Invitrogen). Primers derived from
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coding regions of respective genes in mouse genome were
used to amplify the target sites. To ensure that the primers
would uniquely amplify the target transcripts, primers for
some of the genes (Osteocalcin, Fabp4, Lpl) were designed
to flank an intron, which allows to further rule out genomic
contamination by simple inspection of product size. PCR
reactions were prepared with 2μl cDNA, 5 pmol of each
primer, 0.5 units of Taq polymerase (Invitrogen, CA), and
final concentrations of 40 μM dNTPs, 2 mM MgCl2, 20
mM Tris–HCl, and 50 μl KCl. Cycling conditions were as
follows: 94°C for 4 min; 30 cycles at 94°C for 1 min, 60°C
for 1 min, 72°C for 1 min; followed by 72°C for 5 min. The
PCR products were separated on 2% agarose gel by elec-
trophoresis, stained with ethidium bromide, visualized
under UV light, and digital images captured with AlphaI-
mager software. Respective tissue samples (bone, cartilage,
and fat from mouse) were used as positive controls to val-
idate the primers, Gapdh was used as a housekeeping
gene, and no template controls (water instead of cDNA)
were used as negative controls.
Western blot analysis. Cells were washed with ice-cold
PBS and then lysed in boiling lysis buffer (1% [w/v], Sodium
dodecylsulfate, 1mM sodium ortho-vanadate and 10 mM
Tris (pH 7.4) for 5 min followed by brief sonication. The lys-
ate was centrifuged at 12,000 x g for 15 min at 4°C. Protein
concentrations were measured with a Bio-Rad DC protein
assay kit (Bio Rad Laboratories Inc., Melville, NY). Total cel-
lular proteins were resolved by 7.5% (w/v) acrylamide gel and
transferred to a polyvinylidene difluoride (PVDF) membrane
(Amersham, Arlington Heights, IL). The membrane was
blocked with 5% non-fat milk in Tris-buffered saline (TBS)
containing 0.1% Tween 20 for 1 hour at room temperature.
The membrane was incubated overnight at 4°C with the one
of the following specific primary antibodies (diluted with 5%
bovine serum albumin in TBS containing 0.1% Tween 20),
followed by HRP-conjugated anti-rabbit IgG antibodies
(Amersham). Bound peroxidase was determined using an
ECL Chemiluminescence detection Kit (Amersham). West-
ern analysis was conducted using primary antibodies specific
for Phospho-STAT3 (Tyr705) (1:1000), Phospho-STAT3
(Ser727) (1:1000), STAT3 (1:1000), Phospho-p44/42 MAP
kinase (Thr202/Tyr204) (1:1000), p44/42 MAP kinase
(1:1000), Phospho-Akt (Ser473) (1:1000), Phospho-Akt
(Thr308) (1:1000), Akt (pan) rabbit mAb (1:1000), Phospho-
PI3K p85(Tyr458) (1:1000) and PI3 Kinase p85 rabbit mAb
(1:1000). To assess loading, membranes were stripped and
reprobed with specific antibodies that recognize both phos-
phorylated and unphosphorylated forms of each protein.
Statistical analyses
Data were reported as mean ± standard error of the mean
(SEM) and were analyzed by the general linear model
(GLM) ANOVA and pairwise comparisons made by Bon-
ferroni method by using Sigma Stat software (Jandel Scien-
tific, San Rafael, CA) when appropriate. Means with
different letters differ at p < 0.05.
Results
Obesity-associated increase in SVF and Sca-1+/CD45-/
CD34+ cell numbers
Using age-matched littermate lean and ob/ob mice, we
isolated adipose tissue SVF cells as well as Sca-1+/CD45-/
CD34+ MSCs. As shown in Figure 1A, adipose tissue
mass was significantly greater (>10×) in the ob/ob mice
Figure 1 Leptin increases plasma MCP-1 and adipose tissue MCP-
1 mRNA. (A). Epididymal adipose tissue MCP-1 mRNA of lean and
ob/ob mice injected with leptin (1 μg/g body weight) for 3 hrs. (B).
Plasma MCP-1 concentration of lean and ob/ob mice injected with
leptin (1 μg/g body weight) for 3 hours. For (A)-(B), the mean ± SE for
eight mice per group are plotted, ** represents p<0.001compared to
lean mice and ## represents p<0.001compared to ob/ob mice.
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compared to lean mice. Results also showed that SVF cell
numbers of ob/ob mice were significantly greater than
that of lean mice (Figure 1B; 22.7 ±2.41 × 106 in ob/ob
versus 2.49 ± 0.14 × 106 in lean mice; p<0.001). Similarly,
Sca-1+/CD45-/CD34+ cell numbers were greater in obese
versus lean animals (Figure 1C; 6.3 ±1.27 × 106 in ob/ob
versus 1.4 ± 0.1 × 106 in lean mice; p<0.05).
Data demonstrated that the total numbers of SVF cells
and CD34+/Sca-1+/CD45- cells were increased in the adi-
pose tissue in ob/ob mice coincident with an equal increase
in total fat mass. In contrast to expectation, normalization
of SVF cell numbers by adipose tissue mass showed
decreases in SVF cell numbers per gram of adipose tissue
in ob/ob mice. In addition, the percent of CD34+/
Sca-1+/CD45- cells in SVF were also reduced in ob/ob mice
because of the increased SVF cell numbers in ob/ob mice.
Leptin increases Sca-1+/CD45-/CD34+ cell numbers in vivo
and in vitro
To test the effects of leptin on Sca-1+/CD45-/CD34+ cell
numbers in vivo, SVF cells from the ob/ob mice that were
injected with saline or leptin (1 μg/gm body weight) for
10 days were isolated. The SVF cells were then analyzed
for Sca-1+/CD45-/CD34+ cell numbers. Data showed that
leptin injection increases percent Sca-1+/CD45-/CD34+
cell numbers (Figure 2A, p<0.05). To test the effects of
leptin in vitro, isolated Sca-1+/CD45-/CD34+ cells were
treated with insulin (1000 ng/ml), leptin (1000 ng/ml)
and leptin (1000 ng/ml) + insulin (1000 ng/ml) for 96 h.
Data showed that leptin and leptin + insulin increase
Sca-1+/CD45-/CD34+ cell numbers (Figure 2B, p<0.05).
Effects of leptin injection to ob/ob mice on Sca-1+/CD45-/
CD34+ cell MCP-1 mRNA expression and MCP-1 secretion
To test effects of leptin in vivo, endotoxin-tested recom-
binant mouse leptin was injected into ob/ob mice. Leptin
replacement increased epididymal adipose tissue MCP-1
Figure 2 Adipose tissue mass, SVF cell and Sca-1+/CD45-/CD34+
cell numbers are increased in ob/ob mice. (A). Adipose tissue
mass of C57BL/6J (lean) and ob/ob (leptin-deficient) mice. (B).
Stromal vascular fraction (SVF) cells were isolated from epididymal
white adipose tissue from lean and ob/ob mice and SVF cell
numbers were quantified using FACS analysis. (C). CD34+ cells
isolated using magnetic column were stained for Sca-1 and CD45
and quantified using FACS analysis. For (A)-(C), the mean ± SE for
eight mice per group are plotted, *p<0.05 compared to lean mice.
Figure 3 Leptin increases Sca-1+/CD45-/CD34+ cell numbers
in vivo and in vitro. (A). Cell numbers were measured using FACS
analysis of SVF cells that were isolated from leptin-injected ob/ob
mice (1 μg/g body weight for 10 days). The mean ± SE for three
mice per group are plotted, *p<0.05 compared to lean mice (B).
Isolated and cultured SVF cells from ob/ob mice were treated with
insulin (1000 ng/ml), leptin (1000 ng/ml) and leptin (1000 ng/ml) +
insulin (1000 ng/ml) for 96h. Cells were quantified using FACS
analysis. Data are presented as mean ± SE, triplicate samples of
n = 3 independent experiments, * represents p<0.05.
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mRNA levels (Figure 3A, p<0.001) and plasma MCP-1
(Figure 3B, p<0.001).
Osteogenic, chondrogenic, and adipogenic differentiation
and cell surface immunophenotypes of Sca-1+/CD45-/
CD34+ cells
To demonstrate that Sca-1+/CD45-/CD34+ cells from
mouse adipose tissue were MSC, their ability to differen-
tiate into 3 major mesodermal lineages, i.e., osteoblasts,
chondrocytes, and adipocytes was tested. Upon induc-
tion with optimized osteogenic differentiation cocktail,
the cell monolayer was extensively covered by Alizarin
red-positive calcified extracellular matrix (Additional file
1: Figure 1A, osteogenic differentiation cocktail (+))
whereas untreated cells did not show morphological
change and remained negative for Alizarin red staining
(Additional file 1: Figure 1A, osteogenic differentiation
cocktail (−)). Osteo-induced cells expressed mRNAs for
osteogenic markers, i.e. Runx2, Col1a, Osterix, Bsp, and
Osteocalcin, all of which were undetectable after 30
cycles of PCR in control cells (not treated with induction
cocktail) (Additional file 1: Figure 1A). Sca-1+/CD45-/
CD34+ cells were seeded at high density in micromass
culture and treated with chondrogenic induction cocktail
that induced the formation of three-dimensional chon-
drogenic cell aggregates within 24 hours (Additional file
1: Figure 1B, chondrogenic differentiation cocktail (+)),
whereas untreated cells remained as high-density mono-
layer cultures (Additional file 1: Figure 1B, chondrogenic
differentiation cocktail (−)). Treated micromass stained
positive for Alcian blue within 2 weeks, indicating the
presence of sulfated proteoglycans, whereas untreated
monolayer did not show any such staining (Additional
file 1: Figure 1B, Alcian blue (+)). Cells in the induced
micromass showed specific expression of Col2α, Comp,
Col10a, and Sox9 mRNAs associated with chondrogen-
esis, all of which were undetectable in monolayer of cells
without induction cocktail (Additional file 1: Figure 1B).
Following the induction with adipocyte differentiation cock-
tail, fat globules were noticed within 3–5 days (Additional
file 1: Figure 1C, adipogenic differentiation cocktail (+)).
These cells stained positive with Oil Red O while no
differentiation was observed in the untreated controls
(Additional file 1: Figure 1C). Expression of mRNAs for
adipogenesis genes Pparγ2, Cebpα, Fabp4, and Lpl were
expressed only in cells that were treated with adipogenic
differentiation cocktail (Additional file 1: Figure 1C). We
used the same cells to determine presence of stem cell
surface markers stem cell antigen-1 (Sca-1) and for the ab-
sence of potential hematopoietic cell marker CD45. Data
showed that these CD34+ cells were totally negative for
CD45 (hematopoietic stem cell marker) and 95.5 ± 4.04 %
of these cells were positive for Sca-1 (mesenchymal stem
cell marker) (Additional file 1: Figure 1D-1F).
Figure 4 Leptin induces MCP-1 secretion and mRNA expression in
adipose stem cells in dose- and time-dependent manner. (A). The
ob/ob mice Sca-1+/CD45-/CD34+ cells seeded as 1 × 106/ml/well in a
24-well culture plate and incubated with leptin (1000 ng/ml) for 24, 48,
and 72 h. The supernatants were collected and MCP-1 protein levels
were determined using ELISA. Data are expressed as mean ± SD, n=3.
**p<0.01 compared to the value for untreated control cultures. ##p<0.01
compared to the value for treated with leptin 24 hours cultures. (B). The
ob/ob mice Sca-1+/CD45-/CD34+ cells were seeded as 5×106/5ml/well in
a 6-well culture plate and incubated for 6 h with various doses of leptin
as indicated. (C). The cells were seeded in a same density as in (B) with
or without leptin (1000 ng/ml) for 3, 6, 12, and 24 h. For (B) and (C), total
RNA were extracted and relative MCP-1 mRNA expression was
determined by real time PCR and normalized against 18S-rRNA. Data are
expressed as mean ± SD, n=3. For (B) and (C), *p<0.05, **p<0.01
compared to the value for untreated control cultures and ##p<0.01
compared to the value for cultures treated with leptin for 3 h cultures.
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Leptin induces MCP-1 secretion and MCP-1 mRNA
expression
To determine whether leptin induces MCP-1 secretion,
adipose CD34+ stem cells were treated with murine re-
combinant leptin (1000 ng/ml) for 24, 48 and 72 h. Lep-
tin significantly and time-dependently increased MCP-1
secretion compared to control at all time points
(Figure 4A, p<0.05). MCP-1 secretion at 48 and 72h fur-
ther increased compared to 24h (Figure 4A, p<0.01) and
reached a plateau between 48 h to 72 h. This suggests
that MCP-1 secretion can be maximally induced by lep-
tin as early as 48 h with the dose of 1000 ng/ml. To test
whether leptin induces MCP-1 mRNA expression in adi-
pose stem cells, we treated cells with varying doses of
leptin (0, 50, 250, 500, and 1000 ng/ml) for 6 h and mea-
sured MCP-1 mRNA using real time RT-PCR. Leptin
significantly increased MCP-1 mRNA levels when added
at 500, and 1000 ng/ml (Figure 4B, p<0.01). Furthermore,
leptin-induced MCP-1 mRNA expression in adipose Sca-1
+/CD45-/CD34+ cells was significantly enhanced compared
to control in a dose-dependent manner and this induction
was time-dependent with peak expression observed at 12h
of leptin stimulation (Figure 4C, p<0.01).
Leptin–induced MCP-1 secretion is blocked by inhibition
of JAK-2, PI3K, ERK, or Akt
To determine whether JAK2 and PI3K/Akt signal pathways
participate in MCP-1 secretion induced by leptin,
Sca-1+/CD45-/CD34+ cells were pretreated with or
without the JAK-2 inhibitor (AG490), ERK inhibitor
(U-0126), PI3 Kinase inhibitor (LY294002) for 1 hour.
Cells were then treated with 1000 ng/ml leptin for
additional 24 hours. All protein inhibitors that were
tested suppressed the leptin-induced MCP-1 produc-
tion (Figure 5, p<0.01). Cell viability (MTT assays)
results suggest that reduction in MCP-1 secretion is
not due to cell toxicity (data not shown).
Leptin-dose dependently activates STAT3, PI3K, Akt, and
ERK1/2
To determine whether leptin activates JAK-STAT and
downstream signaling regulators, Sca-1+/CD45-/CD34+
cells were treated with leptin concentrations of 0, 250,
500 to 1000 ng/ml to test whether phosphorylation of
these leptin signaling intermediates were altered. Leptin
increased phosphorylation of STAT3, Akt, and ERK1/2
at dose ranges of 250 to 1000 ng/ml while increased
phosphorylation of PI3K was observed at 500 to 1000
ng/ml leptin (Figure 6).
Leptin-mediated STAT3, PI3K, Akt, and ERK1/2 activation
is prevented by JAK-2 inhibitor
To test if inhibition of JAK-2 results in decreases in down-
stream leptin signaling pathway, Sca-1+/CD45-/CD34+ cells
were treated with JAK-2 inhibitor and tested for phosphor-
ylation of PI3K, Akt, ERK1/2 and STAT3. Leptin-induced
phosphorylation of PI3K, Akt, ERK1/2 and STAT3 were
inhibited by JAK-2 inhibitor (Figure 7A-7D).
Figure 5 Leptin induced MCP-1 secretion is decreased by JAK-2, ERK, PI3K, and Akt inhibitors. The Sca-1+/CD45-/CD34+ cells from ob/ob
mice were seeded as 1 × 106/ml/well in a 24-well culture plate and pretreated with or without 50 μM of the JAK 2 inhibitor AG490, 0.5 μM of the
JAK2 inhibitor JAK inhibitor I, 10 μM of the ERK inhibitor U-0126, 200 μM of the PI3 Kinase inhibitor LY294002, and 10 μM of the Akt inhibitor Akt
inhibitor IV for 1 h. After 1h pretreatment, cell culture media were removed and cells were treated with leptin (1000 ng/ml) in media containing
the same concentration of inhibitor for additional 24h. The supernatants were collected and determined by MCP-1 ELISA. Data are expressed as
mean ± SD. **p<0.01 compared to the value for untreated control cultures. ##p<0.01 compared to the value for cultures subjected to leptin
without inhibitor pretreatment.
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Determination of downstream leptin signaling pathway
sequence
To determine the sequence of events that leads to leptin-
induced MCP-1 gene expression in Sca-1+/CD45-/CD34+
cells, cells were treated with leptin. Starting with a well-
established leptin JAK-STAT signaling pathway, PI3K in-
hibitor was added to determine if phosphorylation of
expected downstream activator-Akt could be inhibited.
PI3K inhibitor decreased expression of phosphorylated Akt
(Figure 8A). We then tested if Akt inhibitor decreased
leptin-induced Akt and ERK1/2 phosphorylation. Inhib-
ition of Akt phosphorylation prevented ERK1/2 phosphor-
ylation (Figure 8B). In addition, ERK inhibitor-mediated
decreases in phosphorylated STAT3 reduced leptin-
induced STAT3 phosphorylation at Ser 727 (Figure 8C).
High levels of phosphorylated STAT3 Tyr 705 were
observed under basal conditions and this unexpected high
expression of phosphorylated STAT3 Tyr 705 was
decreased in the presence of ERK inhibitor and leptin.
Discussion
The current study demonstrated that ob/ob mice exhibit
significantly greater adipose tissue mass, SVF and
adipose MSC cell numbers as well as greater circulating
MCP-1 and adipose MCP-1 expression. Data also
showed that mesenchymal stem cells from adipose tissue
of adult ob/ob mice exhibit hyperplasia and are respon-
sive to obesity-related endocrine factors such as leptin.
Noteworthy is that leptin deficient mice exhibit hyper-
plasia partly due to increased concentrations of other
obesity-associated endocrine and mitogenic factors such
as insulin and IL-6. Although an absence of leptin in ob/
ob mice still showed increased inflammation compared to
the lean mice, data from our current study showed that
injected leptin cause even greater hyperplasia beyond the
leptin-deficient state. Data demonstrating decreases in
SVF cell numbers per gram of adipose tissue in ob/ob
mice and decreases in percent of CD34+/Sca-1+/CD45-
cells in SVF in ob/ob mice were opposite to our initial
expectation that obesity induces hyperplasia of adipo-
cytes as well as their precursor cells including SVF
and CD34+/Sca-1+/CD45- cells. However, our data are
consistent with another study which showed an increase
in the total number of stromal cells with increased adipos-
ity and a negative correlation between adiposity and num-
ber of stromal cells per gram of adipose tissue [39].
P-STAT3 86 kDa
Leptin (ng/ml)
- 250     500    1000 
STAT3 86 kDa
P-PI3K 85 kDa
Leptin (ng/ml) - 250     500    1000 
PI3K 85 kDa
P - Akt 60 kDa
Leptin (ng /ml)
- 250     500    1000 
Akt 60 kDa
(A)
(B)
(C)
(D)
Figure 6 Leptin-dose dependently increases activation of STAT3, PI3K, Akt, and ERK1/2. The Sca-1+/CD45-/CD34+ cells from ob/ob mice
were seeded as 1 × 107/10ml/dish in a 100 mm × 20 mm culture dish. The cells were incubated with various dose of leptin (0, 250, 500 and 1000
ng/ml) for 30 min. Total cellular proteins were extracted and subjected to western blot analysis with antibodies specific for (A). anti-phospho-
STAT3, (B). anti-phospho-PI3K p85(Tyr458), (C). anti-phospho-Akt, and (D). anti-phospho-p44/42 ERK (Thr202/Tyr204) as indicated. Bands were
detected using the ECL system. Afterward, blots were stripped and reprobed with anti-STAT3, anti-PI3K p85, anti-Akt (pan), and anti-p44/42 ERK
antibody for assessment of protein loading. Results shown are representative of three independent experiments.
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Added statement (line 3, p 17): In our current study
we showed that plasma levels of MCP-1 in ob/ob mice,
is elevated compared to control mice, in spite of leptin
deficiency. However, it is plausible that ob/ob mice have
elevated MCP-1 because of obesity that is a secondary
response to leptin deficiency. To address whether leptin
can directly upregulate MCP-1, we gave ob/ob mice a
single injection of leptin for short term (3 hrs) and also
long term (7 days). The plasma MCP-1 levels measured
from ob/ob mice injected with leptin for 7 days showed
significant decreases in body weight as demonstrated
previously [40] and at the same time plasma MCP-1
levels decreased significantly (55 + 4.5 pg/ml) compared
to ob/ob mice that were injected with saline for 7
days as a control (67 + 4.7 pg/ml). Taken together
these results suggest that that leptin itself can directly
upregulate MCP-1 and that MCP-1 levels in ob/ob mice
are decreased subsequent to body weight reduction.
We previously reported that the basal adipose tissue
MCP-1 mRNA level was greater in the leptin deficient
ob/ob mice, possibly due to a greater number of MCP-1
secreting adipose stem cells [5]. The current study
showed that leptin-treated ob/ob mice exhibit greater
levels of adipose tissue MCP-1 mRNA and plasma
MCP-1. Using adipose MSC cells isolated from ob/ob
mice, we further demonstrated that the number of these
adipose MSC cells is increased proportionally to adipose
tissue mass. Moreover, we determined that these cells
exhibit MSC phenotypes that include multilineage differ-
entiation potential into mesenchymal cell types and
showed that these cells express well-known markers of
MSC (Additional file 1: Figure 1). One noteworthy
(A)
(B)
(C) 
(D)
JAK-2 inhibitor
Leptin
- +           - +     
- - +         +
P-PI3K
PI3K 85 kDa
85 kDa
Leptin
- +          - +     
- - +        +
P-STAT3 Ser727
STAT3 86 kDa
86 kDa
P-STAT3 Tyr 705 86 kDa
JAK-2 inhibitor
Figure 7 Leptin–induced MCP-1 expression is inhibited by JAK-2 inhibitor, PI3K inhibitor, ERK inhibitor and Akt inhibitor. The
Sca-1+/CD45-/CD34+ cells were seeded as 1 ×107/10ml/dish in a 100 mm × 20 mm culture dish. The cells were pre-incubated with 50 μM of the
JAK 2 inhibitor AG490 for 1 h. After 1 hr, cell culture media was removed and fresh media containing leptin (1000 ng/ml) and 50 μM of the JAK2
inhibitor was added for additional 30 minutes. Total cellular proteins were extracted and subjected to western blot analysis with (A).
anti-phospho-PI3K, (B). anti-phospho-Akt (C). anti-phospho-p44/42 ERK, and (D), anti-phospho-STAT3 (Ser727) and anti-phospho-STAT3 (Tyr705)
antibody as indicated. Bands were detected using the ECL system. Afterward, blots were stripped and reprobed with anti-STAT3, anti-PI3K p85,
anti-Akt (pan), and anti-p44/42 ERK antibody for assessment of protein loading. Results shown are representative of three independent
experiments.
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finding of this study is that cell surface CD45 antigen is
absent in these adipose MSC cells.
To date, no studies have addressed whether obesity-
associated endocrine factors such as leptin, regulate adipose
stem cell-derived MCP-1, nor have they dissected the intra-
cellular signaling intermediates involved in leptin-mediated
MCP-1 gene expression in the stem cells. Accordingly, we
sought to characterize the molecular mechanisms under-
lying obesity-associated increases in adipose tissue MCP-1
concentrations. Specifically, we characterized leptin-
induced intracellular signaling pathways that lead to
increased MCP-1 secretion and gene expression. We identi-
fied two separate signaling pathways leading to MCP-1
gene expression regulation in Sca-1+/CD45-/CD34+ adipose
MSC cells. Under the basal conditions, these cells express
constitutively activated Tyr705 in STAT3, which was
decreased by leptin treatment. In contrast, STAT3 Ser
727 was expressed at low levels in basal conditions and
was activated by leptin. The exact mechanism of this dif-
ferential regulation of STAT3 Tyr705 and Ser727 is not
known. Activation of the STAT3 first requires STAT3
Tyr705 phosphorylation-induced dimerization of the cyto-
kine receptor and the STAT3 activity is subsequently
modulated by phosphorylation at Ser727 with various
stimuli [41,42]. Other studies have suggested that activa-
tion of STAT Ser727 is independent of activation of
STAT3 Tyr705 [42] and that while both Tyr705 and Ser
727 are essential for full activation of STAT3 pathway,
only STAT3 Ser 727 phosphorylation is triggered by ex-
ogenous stimuli such as insulin, TNF-alpha, and lipopoly-
saccharide [42]. In addition, exposure of mouse epidermal
tumor prone JB6 cells to UV radiation triggered only
STAT3 Ser 727 phosphorylation and not STAT3 Tyr705
[42]. Downstream kinase of ERK that can independently ac-
tivate Ser 727 and Tyr705A of STAT3 has been explored
and the findings suggested that mitogen- and stress-
activated protein kinase 1 (MSK1) may specifically phos-
phorylate STAT3 Ser 727 [42]. Interestingly, STAT3 Ser727
phosphorylation negatively regulates STAT3 Tyr705 by
dephosphorylating STAT3 Tyr705 [43]. In one study, leptin
added at 2 nM stimulated phosphorylation of both STAT3
Tyr705 and Ser727 in murine macrophage cell line J774.2
(A)
(B) 
(C) 
PI3K inhibitor
Leptin
P-Akt Ser473
Akt
- +           - +     
- - + +
60 kDa
60 kDa
P-Akt Thr308 60 kDa
ERK inhibitor 
Leptin
- +          - +     
- - +        +
P-STAT3 Ser727
STAT3 86 kDa
86 kDa
P-STAT3 Tyr 705 86 kDa
Figure 8 Determination of downstream leptin signaling pathway sequence. The Sca-1+/CD45-/CD34+ cells were seeded as 1 × 107/10ml/
dish. Cells were then pre-incubated with 200 μM of the PI3 Kinase inhibitor LY294002, 10 μM of the Akt inhibitor IV, and 10 μM of the ERK
inhibitor U-0126 for 1 h. After 1 hr, cell culture media was removed and fresh media containing leptin (1000 ng/ml) and the same inhibitors were
added for additional 30 min. Total cellular proteins were extracted and subjected to western blot analysis with (A). anti-phospho-Akt (B). anti-
phospho-p44/42 ERK, and (C), anti-phospho-STAT3 (Ser727) and anti-phospho-STAT3 (Tyr705) antibody as indicated. Bands were detected using
the ECL system. Afterward, blots were stripped and reprobed with anti-STAT3, anti-PI3K p85, anti-Akt (pan), and anti-p44/42 ERK antibody for
assessment of protein loading. Results shown are representative of three independent experiments.
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cells [41]. This finding contrasts our current study in which
leptin decreased constitutively and highly expressed
phopho-STAT3 Tyr705, only if added at concentrations
higher than 50 nM. This difference may be related to the
difference in cell types used in two studies, i.e., transformed
J774.2 cells vs. primary Sca-1+/CD45-/CD34+ cells in our
study. It is plausible that observed high basal levels of
STAT3 Tys705 in our ob/ob mice adipose MSC cells may
be indicative of malignant phenotype or transformed cells.
However, our data from the anchorage-independent growth
(AIG) test (used to test for malignancy by characterizing
the cells that do not require a solid platform such as the
plastic surface of the culture dish for their growth) demon-
strated that our Sca-1+/CD45-/CD34+ cells are not cancer-
ous cells (data not shown). The possible reason for very
high levels of phospho-STAT3 Tyr 705 is currently un-
known and warrants further investigation.
Conclusions
Our data demonstrated that adipose MSC cell number sig-
nificantly increased with leptin injection and that leptin up-
regulated MCP-1 secretion in a dose- and time-dependent
manner. We further showed that increases in MCP-1
mRNA levels in the adipose stem cells were due to
increased phosphorylation of STAT3 Ser727, but not due
to changes in STAT3 Tyr705 phosphorylation suggesting
differential regulation of MCP-1 gene expression under
basal and leptin-stimulated conditions in adipose stem cells
(Figure 9). Identification of factors regulating adipose MSC
cell number and production of proinflammatory
adipokine such as MCP-1, as well as dissection of
leptin modulated signaling pathway in these cells may
help in developing novel anti-obesity target strategies.
Additional file
Additional file 1: Figure 1. Sca-1+/CD45-/CD34+ cells from ob/ob mice
have multilineage differentiation potential. (A). Osteogenic differentiation
of mouse adipose tissue derived CD34+ mAd-MSCs. MACS-separated cells
were treated with osteogenic differentiation cocktail for 4 weeks. Alizarin
red-positive mineralized deposits were present in the cells that were
treated with osteogenic differentiation cocktail (+), but not in control
cells that were not treated with osteogenic differentiation cocktail (−).
Cells were treated with and without osteogenic differentiation cocktail
for total RNA isolation. Levels of mRNA for osteogenic marker gene
Runx2, Col1a1, Osterix (Osx), Osteocalcin (Oc), Bone sialoprotein (Bsp) and
housekeeping Gapdh gene were determined using RT-PCR methods. (B).
Chondrogenic differentiation of mouse adipose tissue derived CD34+
mAd-MSCs. Cells were treated with chondrogenic differentiation cocktail
for 2 weeks. Formation of micromass that is stained positive with sulfated
proteoglycan-specific Alcian blue was seen in cells that were treated with
chondrogenic differentiation cocktail (+) but not in control cells that
were not treated with chondrogenic differentiation cocktail (−). Cells
were treated with and without chondrogenic differentiation cocktail for
total RNA isolation. Levels of mRNA for chondrogenic marker gene Col2a,
Col10a, Comp, Sox9 and housekeeping Gapdh gene were determined
using RT-PCR methods. (C). Adipogenic differentiation of mouse adipose
tissue derived CD34+ mAd-MSCs. Cells were treated with adipogenic
differentiation cocktail for 2 weeks. Lipid accumulation was detected
using Oil Red O staining in cells that were treated with adipogenic
differentiation cocktail (+) but not in control cells that were not treated
with adipogenic differentiation cocktail (−). Cells were treated with and
without adipogenic differentiation cocktail for total RNA isolation. Levels
of mRNA for adipogenic marker gene Pparγ2, Cebpα, Fabp4, Lpl and
housekeeping Gapdh gene were determined using RT-PCR methods. For
(A)-(C), images (100×) are representative of three independent
experiments and RT-PCR results are from pooled total RNA sample of
three independent samples.
Figure 9 Proposed leptin signaling pathway in adipose Sca-1+/CD45-/CD34+ MSC cells. Post leptin-leptin receptor binding and receptor-
receptor dimerization, JAK-2 is phosphorylated. Activation of JAK-2 results in phosphorylation of PI3K which lead to phosphorylation of Akt and
ERK1/2. Leptin-induced increase in phosphorylated ERK1/2 induces activation of STAT3 by phosphorylating Ser 727 amino acid residue. Under
basal condition, alternative STAT3 Tyr 705 gets phosphorylated. Consequently, activated STAT3 translocates to nucleus and induces MCP-1 gene
transcription in Sca-1+/CD45-/CD34+ MSC cells.
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